Masters Neurotoxins/Dermal Fillers
*You are now in the CME section of our website
Combined Use of Neurotoxins (BoNTA) & Dermal Fillers for Facial Enhancement: Masters Techniques
Masters level Neurotoxin (BoNTA) /Dermal Filler technique course. This course is designed for the practitioner with broad experience with aesthetic injectables and cosmetic procedures. The course will include extensive hands on injecting experience in best practices and latest, most innovative injecting techniques for global facial rejuvenation and sculpting.
Requirements: A minimum of 3+ years experience routinely injecting either of the FDA approved neurotoxin products for cosmetic use and FDA approved dermal fillers. (Admittance subject to approval after an evaluation of a detailed clinical experience questionnaire).
Sample Program Agenda
8:00am – 12:00pm
Didactic Lecture on Dermal Fillers and Botulinum Toxins
12:00pm – 12:30pm
12:30pm – 4:45pm
Hands-On Training for Dermal Fillers and Botulinum Toxins with Live Injections
4:45pm – 5:00pm
Review, Discussion, Q&A
Masters course instruction includes all sites included in our Advanced Courses as well as:
Dermal Filler Sites:
*Indicates off-label sites
- Blunt tip cannula technique*
- Temporal hollows*
- Tear trough/nasojugal fold*
- nasal contour irregularities*
- lateral brow*
- cheek augmentation*
- preauricular volume loss*
- jawline contouring*
BoNTA: mesotoxin therapy to nontraditional sites:
- lateral smile lines*
- knee creases*
- inferior crow’s feet*
Upon successful completion of the activities, participants will be able to:
- Utilize alternative injecting techniques and dosages of neurotoxins and/or dermal fillers beyond their current experience safely and efficaciously into previously injected treatment sites.
- Introduce safe and efficacious treatment of neurotoxins and/or dermal fillers to injection sites not previously treated.
- Recognize and implement appropriate treatment protocol of injected treatment sites.
Method of Participation
Statements of credit will be awarded based on the participant’s attendance. A statement of credit will be available upon completion of an online evaluation/claimed credit form available at www.akhcme.com/aai. To avoid issues with your spam filter, please list firstname.lastname@example.org as an approved email address.
If you have questions about this CME activity, please contact AKH Inc. at email@example.com.
CME/CE Credit Provided by AKH Inc., Advancing Knowledge in Healthcare
Physician Continuing Medical Education
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Aesthetic Advancements Inc.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation
AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCPA accepts AMA PRA Category I Credit(s)™ from organizations accredited by ACCME.
AKH Inc., Advancing Knowledge in Healthcare is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity is awarded 8.5 contact hours.
AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.
Provider Number: 030803.
This activity is awarded 8.5 contact hours which includes 0 hours of pharmacology. Program ID #21524.
There is no commercial support for this activity
It is the policy of AKH Inc. and AAI to ensure independence, balance, objectivity, scientific rigor, and integrity in all of its continuing education activities. The author must disclose to the participants any significant relationships with commercial interests whose products or devices may be mentioned in the activity or with the commercial supporter of this continuing education activity. Identified conflicts of interest are resolved by AKH prior to accreditation of the activity and may include any of or combination of the following: attestation to non-commercial content; notification of independent and certified CME/CE expectations; referral to National Author Initiative training; restriction of topic area or content; restriction to discussion of science only; amendment of content to eliminate discussion of device or technique; use of other author for discussion of recommendations; independent review against criteria ensuring evidence support recommendation; moderator review; and peer review.
AKH Inc. and AAI planners and reviewers have no relevant financial relationships to disclose.
Disclosure of Unlabeled Use and Investigational Product
This educational activity may include discussion of uses of agents that are investigational and/or unapproved by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
This course is designed solely to provide the healthcare professional with information to assist in his/her practice and professional development and is not to be considered a diagnostic tool to replace professional advice or treatment. The course serves as a general guide to the healthcare professional, and therefore, cannot be considered as giving legal, nursing, medical, or other professional advice in specific cases. AKH Inc. specifically disclaim responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through participant’s misunderstanding of the content.
*Program subject to change.